Tilray Brands, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TLRY research report →
Companywww.tilray.com
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business.
- CEO
- Irwin David Simon
- IPO
- 2018
- Employees
- 2,650
- HQ
- Leamington, ON, CA
Price Chart
Valuation
- Market Cap
- $647.06M
- P/E
- -0.33
- P/S
- 0.55
- P/B
- 0.39
- EV/EBITDA
- -0.41
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 27.67%
- Op Margin
- -172.33%
- Net Margin
- -156.18%
- ROE
- -92.82%
- ROIC
- -100.85%
Growth & Income
- Revenue
- $1.13B · 4.84%
- Net Income
- $-3,000,620,016 · -798.92%
- EPS
- $-33.80 · -651.11%
- Op Income
- $-3,132,304,973
- FCF YoY
- -113.48%
Performance & Tape
- 52W High
- $23.20
- 52W Low
- $3.50
- 50D MA
- $6.42
- 200D MA
- $9.71
- Beta
- 1.94
- Avg Volume
- 4.48M
Get TickerSpark's AI analysis on TLRY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 21, 26 | Hopkinson David G. | sell | 33,556 |
| Jan 7, 26 | Cohen Steven Michael | other | 12,438 |
| Jan 7, 26 | Cohen Steven Michael | other | 12,438 |
| Jul 31, 25 | SIMON IRWIN D | other | 706,216 |
| Jul 31, 25 | SIMON IRWIN D | other | 374,295 |
| Jul 31, 25 | SIMON IRWIN D | other | 353,108 |
| Jul 31, 25 | Merton Carl A | other | 93,928 |
| Jul 31, 25 | Merton Carl A | other | 49,782 |
| Jul 31, 25 | Merton Carl A | other | 46,964 |
| Jul 31, 25 | Gendel Mitchell | other | 93,928 |
Our TLRY Coverage
We haven't published any research on TLRY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TLRY Report →